药康生物股价涨1.12%，天弘基金旗下1只基金重仓，持有248.6万股浮盈赚取42.26万元

Group 1 - Jiangsu Jicui Yaokang Biotechnology Co., Ltd. is located in Nanjing, Jiangsu Province, and was established on December 29, 2017, with its listing date on April 25, 2022 [1] - The company's main business involves the research, production, sales, and related technical services of laboratory animal mouse models, with the revenue composition being: commercial mouse model sales 55.36%, functional efficacy 23.46%, custom breeding 11.32%, model creation 7.06%, import-export agency and others 2.70%, and other (supplementary) 0.09% [1] Group 2 - Tianhong Medical Health A (001558) holds a significant position in its portfolio with a 8.88% net value proportion, being the second-largest heavy stock, having reduced its holdings by 645,200 shares to 2,486,000 shares [2] - The fund has achieved a return of 30.63% this year, ranking 3092 out of 8085 in its category, and a return of 28.76% over the past year, ranking 3069 out of 8085 [2] Group 3 - The fund manager of Tianhong Medical Health A is Lü Qiao, who has been in the position for 364 days, with the fund's total asset size at 506 million [3] - During Lü Qiao's tenure, the best fund return was 35.36%, while the worst was 34.83% [3]